Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method.

This study provides evidence for better understanding the pharmacokinetics and potential for clinical guidance of XBJ for TBI treatment.
PMID: 31524030 [PubMed - as supplied by publisher]

Source: Xenobiotica - September 15, 2019 Category: Research Authors: Sheng C, Peng W, Xia Z, Wang Y Tags: Xenobiotica Source Type: research